CO4340557A1 - PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE - Google Patents

PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE

Info

Publication number
CO4340557A1
CO4340557A1 CO95039806A CO95039806A CO4340557A1 CO 4340557 A1 CO4340557 A1 CO 4340557A1 CO 95039806 A CO95039806 A CO 95039806A CO 95039806 A CO95039806 A CO 95039806A CO 4340557 A1 CO4340557 A1 CO 4340557A1
Authority
CO
Colombia
Prior art keywords
acid
combination
derivative
reactionable
carbonate
Prior art date
Application number
CO95039806A
Other languages
Spanish (es)
Inventor
Patrick John Crowley
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority to CO95039806A priority Critical patent/CO4340557A1/en
Publication of CO4340557A1 publication Critical patent/CO4340557A1/en

Links

Abstract

UNA FORMULACION FARMACEUTICA SOLIDA PARA ADMI- NISTRACION ORAL, QUE COMPRENDE EN COMBINACION CLA- VULANTE Y UN ACIDO ORGANICO FARMACEUTICAMENTE ACEPTABLE O UN DERIVADO SALINO DEL MISMO FARMACEU- TICAMENTE ACEPTABLE O DE COMPONENTES QUE PUEDAN REACCIONAR CONJUNTAMENTE PARA FORMAR DICHO DERIVA- DO SALINO, CON LA EXCLUSION DE: ACIDO SUCCINICO, ACIDO TARTARICO, ACIDO CITRICO O ACIDO MALICO CUANDO ESTOS ACIDOS FORMAN UN COMPONENTE DE UNA PAREJA EFERVESCENTE CON UN CARBONATO DE METAL AL- CALINO O CARBONATO EN UNA TABLETA MASTICABLE; DE LA COMBINACION DE SUCCINATO DE DISODIO Y ACIDO SUCCINICO; Y DE ALMIDON GLICONATO DE SODIO EN UNA RELACION DE ALMIDON GLICONATO DE SODIO: CLAVULA- NATO DE < 1 : 1.4. 2UN METODO PARA LA PREPARACION DE UNA FORMULA- CION FARMACEUTICA DE ACUERDO CON LA REIVINDICACION 1, CUYO METODO COMPRENDE LA INCORPORACION DE LA COMBINACION DE CLAVULANATO Y EL MENCIONADO ACIDO ORGANICO FARMACEUTICAMENTE ACEPTABLE Y/O EL DERI- VADO SALINO FARMACEUTICAMENTE ACEPTABLE DEL MISMO O DE COMPONENTES QUE PUEDAN REACCIONAR CONJUNTA- MENTE PARA FORMAR TAL DERIVADO SALINO, OPCIONAL- MENTE CON UN ANTIBIOTICO.A STRONG PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION, COMPRISING IN A CLAVING COMBINATION AND A PHARMACEUTICALLY ACCEPTABLE ORGANIC ACID OR A SALINE DERIVATIVE OF THE SAME PHARMACEUTICALLY ACCEPTABLE, SUCCESSFUL, AND MAY BE REACTIONABLE, RECIPIENT, AND MAY BE REACTIONABLE. EXCLUSION OF: SUCCINIC ACID, TARTARIC ACID, CITRIC ACID OR MALIC ACID WHEN THESE ACIDS FORM A COMPONENT OF AN EFFERVESCENT COUPLE WITH A CARBONATE OF ALKALINE METAL OR CARBONATE IN A CHEWABLE TABLET; OF THE COMBINATION OF DISODIUM SUCCINATE AND SUCCINIC ACID; AND OF SODIUM GLYCONATE STARCH IN A RATE OF SODIUM STARCH GLYCONATE: CLAVULA- NATO OF <1: 1.4. 2A METHOD FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION IN ACCORDANCE WITH CLAIM 1, WHICH METHOD INCLUDES THE INCORPORATION OF THE CLAVULANATE COMBINATION AND THE SOCIALLY ACCEPTED FARMACEUTICALLY ACCEPTABLE AND / OR THE DERIVATIVE COMPUTER THAT THEY CAN REACTION TOGETHER TO FORM SUCH A SALINE DERIVATIVE, OPTIONALLY WITH AN ANTIBIOTIC.

CO95039806A 1995-09-01 1995-09-01 PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE CO4340557A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO95039806A CO4340557A1 (en) 1995-09-01 1995-09-01 PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO95039806A CO4340557A1 (en) 1995-09-01 1995-09-01 PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE

Publications (1)

Publication Number Publication Date
CO4340557A1 true CO4340557A1 (en) 1996-07-30

Family

ID=40909487

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95039806A CO4340557A1 (en) 1995-09-01 1995-09-01 PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE

Country Status (1)

Country Link
CO (1) CO4340557A1 (en)

Similar Documents

Publication Publication Date Title
IT1245761B (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
ATE151285T1 (en) ORAL MEDICINAL PRODUCTS WITH COLON-SPECIFIC RELEASE
AU2584192A (en) Bone-growth-stimulating composition
LU90677I2 (en) Esomeprazole and its pharmaceutically acceptable salts and derivatives (nexiam)
ITFI930247A1 (en) ANTAGONISTS OF TACHYCININS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL FORMULATIONS.
IL111519A0 (en) Sustained release tablets having an insoluble active ingredient therein and methods for the preparation thereof
DE69105040T2 (en) Medicines for impotence.
LTIP1722A (en) Therapeutically active substituted benzimidazole and process for its preparation
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
NO950134L (en) Formulations for orally administered pharmaceutical agents
CO4340557A1 (en) PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE
DE69103724T2 (en) PHARMACEUTICAL COMPOSITIONS WITH DELAYED RELEASE FOR ORAL ADMINISTRATION AND THEIR PRODUCTION METHOD.
AR003408A1 (en) CLAVULANATE SALT WITH BENZIDRILAMINE, PREPARATION PROCESS AND PHARMACEUTICAL FORMULATION CONTAINING IT.
ES8303915A1 (en) Pharmaceutical composition of phosphonomicin in tablet form.
AU560185B2 (en) Penicillin derivatives
ATE181828T1 (en) ORAL MEDICINAL PRODUCT CONSISTING OF IBUPROFEN
IT1238205B (en) For of oral administration of creatine phosphate and relative pharmaceutical composition
CO4370015A1 (en) PHARMACEUTICAL FORMULATION UNDERSTANDING AMOXICILLIN AND POTASSIUM OF CLAVULANATE